Diagnostyka company profile

DIA · GPW · PLN

Compare Diagnostyka
zł 151.00Change from previous close: +1.48%Absolute change: +zł 2.20

Close · November 20, 2026

Company profile

Diagnostyka has 8,645 employees and is headquartered in Kraków, Poland.

Based in Kraków, Diagnostyka S.A. has been active since 1998 as a medical laboratory serving clients across Poland. Its offer combines imaging procedures, namely magnetic resonance imaging, computed tomography, X-ray and ultrasound, with specialised laboratory research in microbiology, autoimmunity, toxicology and molecular biology. The company also carries out human genome research, histopathological and cytological examinations, immunohistochemical tests and cytogenetic tests. Its customers are individual clients as well as public and private entities. Its activities are concentrated in Poland.

In the fiscal year ended 31 December 2025, revenue reached 2.4 billion PLN, an increase of 23.6% on the prior year, and net profit came to 251.6 million PLN. The company has 8,645 employees and its headquarters are in Kraków, where it was founded in 1998.

Company facts

Industry
Diagnostics & Research
Country
Poland
Headquarters
Ul. Prof. Michala Zyczkowskiego 16, 31-864, Kraków
Employees
8,645
Chief executive
Jakub Swadzba
Founded
1998
Fiscal year
January - December
Listing
DIA · GPW
Currency
PLN
ISIN
PLDGNST00012
Website
diag.pl

Diagnostyka and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
DiagnostykaDIAPoland$1.27B8,64514.9%20.2
DiaSorinDIAItaly$4.21B3,21222.3%28.6
QiagenQIAGermany$10.23B5,40026.7%28.5
bioMérieuxBIMFrance$11.82B14,56216.0%23.4
Eurofins ScientificERFFrance$16.03B65,00014.1%29.6
Lonza GroupLONNSwitzerland$54.2B20,14123.5%43.2

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Diagnostyka with its competitors